Sound Income Strategies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sound Income Strategies’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-123	Closed	-$15.8K	–	2412
2026 Q1	$15.8K	Buy	123 +34	+38%	+$4.24K	﹤0.01%	1288
2025 Q4	$11.1K	Buy	89 +82	+1,171%	+$9.4K	﹤0.01%	1411
2025 Q3	$746	Hold	7	–	–	﹤0.01%	1486
2025 Q2	$581	Buy	+7	New	+$558	﹤0.01%	1437
2025 Q1	–	Hold	0	–	–	–	1555
2024 Q4	–	Hold	0	–	–	–	1469

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sound Income Strategies's XBI Position: Q2 2026 in Review

Sound Income Strategies sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 123 shares — an estimated $15.8K sold.

Sound Income Strategies first reported a position in XBI in Q2 2025 and held it in 4 quarters. The position peaked at $15.8K in Q1 2026. 692 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Sound Income Strategies reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
Sound Income Strategies sold 123 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $15.8K.
Sound Income Strategies first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and held it in 4 quarters.
Sound Income Strategies's State Street SPDR S&P Biotech ETF position peaked at $15.8K in Q1 2026.
692 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.